mik1とwee1は,cdc2の抑制チロシンリン酸化に協力する
K Lundgren1, N Walworth, R Booher
1Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, New York 11724.
Cell
|March 22, 1991
まとめ
mik1およびwee1キナーゼは,S. pombeのcdc2酸化を制御することによって細胞分裂を調節する. 両キナーゼの喪失は,致命的な細胞サイクルバイパスにつながり,M相チェックポイントに不可欠であることを示唆しています.
科学分野:
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- Wee1キナーゼは,cdc2の活性を調節するCdc25フォスファターゼをアンタゴニズする.
- cdc2のチロシンリン酸化におけるWee1の正確な役割は不明である.
- Mik1はWee1に関連したキナーゼで,機能は不明です.
研究 の 目的:
- S. pombeの細胞周期調節におけるMik1の役割を調査する.
- Mik1 と Wee1.1 の機能的関係を決定する.
- Mフェーズにおけるcdc2調節のメカニズムを解明する.
主な方法:
- S. pombe. の mik1 と wee1 ヌル変異体の構築と分析.
- M相のチェックポイントと細胞サイクル進行の評価.
- 様々な突然変異の背景におけるcdc2チロシンリン酸化状態の分析.
主要な成果:
- Mik1 は Wee1 と冗余的に作用し,cdc2.2 を負の調節する.
- mik1 wee1 のダブルミュータントは,M段階の重要なチェックポイントを回避して,ハイパーミトス的な致死性を示す.
- Mik1とWee1の欠如は,cdc2チロシンの急速な脱酸化につながります.
結論:
- Mik1とWee1は,cdc2.2.の抑制チロシンリン酸化に協力する.
- これらのキナーゼは,M相の整合性とチェックポイントの制御を維持するために不可欠です.
- この研究結果から,Mik1とWee1は直接的な阻害キナーゼか,またはcdc2.2に対する阻害キナーゼの必須活性化剤であることが示唆される.
関連する概念動画
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:17Separation of Sister Chromatids
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...